Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Teplizumab as Prophylaxis Therapy
Treatment of Hyperglycemia in Patients with Acute Ischemic Stroke
FreeStyle Libre FGM in Patients with Type 2 Diabetes
MOST POPULAR ARTICLES OF THE MONTH
#1 Updated Consensus Report on Diabetic Nutrition Therapy
#2 Oral Insulin (ORMD-0801) Close to Reality
#3 Metformin Reduces Hospitalizations Associated with Heart Failure
Editor's Note
I was speaking with our intern Usif Darwish, PharmD Candidate, Florida A&M University, about the causes of type 1 diabetes, and he focused on autoimmune problems destroying the beta cells.
He wondered out loud if using an autoimmune blocking drug would prevent diabetes in relatives of patients already diagnosed.
As you probably guessed, his thought became his assignment, and this week he brings us a feature on the value of using a monoclonal antibody drug.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
The study findings shed light on the viability of a potential prophylactic treatment of type 1 diabetes in direct relatives of current patients.
SHINE study assesses outcomes of aggressive vs standard blood glucose treatments.
Patients with type 2 diabetes routinely use self-monitoring of blood glucose, but what if there was a better option?
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.